Provexis Plc (PXS.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 708 | 189 | 379 | 864 | 1,077 |
| Inventories | 202 | 137 | 328 | 86 | 61 |
| Other current assets | 102 | 172 | 139 | 177 | 155 |
| TOTAL | $1,012 | $498 | $846 | $1,127 | $1,293 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1,012 | $498 | $846 | $1,127 | $1,293 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 28 | 21 | 20 | 25 | 21 |
| TOTAL | $248 | $307 | $188 | $158 | $151 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 534 | 534 | 532 | 530 | 514 |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $248 | $307 | $188 | $158 | $151 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,345,891 | N/A | N/A | N/A | N/A |
| Common Shares | 2,346 | 2,218 | 2,218 | 2,211 | 2,211 |
| Retained earnings | -27,080 | -26,796 | -26,331 | -25,986 | -25,829 |
| Other shareholders' equity | 6,599 | 6,599 | 6,599 | 6,599 | 6,599 |
| TOTAL | $1,298 | $724 | $1,190 | $1,499 | $1,656 |
| Total Liabilities And Equity | $1,546 | $1,032 | $1,378 | $1,657 | $1,807 |